Company intelligence / Profile preview

Gnome Diagnostics

Powell, Ohio, United States

Ownership: Private
Employees: ~25
Development stage: Other

Overview

Commercial-stage CLIA-certified personalized medicine company and contract research organization. It provides pharmacogenomic testing services (GnomeDX) to guide medication prescriptions for over 150 drugs across therapeutic areas like cardiology, mental health, and pain management. Its contract research division (Gnome Sciences) offers comprehensive molecular biology and histopathology services for preclinical and clinical research, and the company also developed COVID-19 diagnostic capabilities.

Therapeutic areas: Infectious DiseasesCardiovascularNeurologyPsychiatry
Industry: Molecular Diagnostics

Beyond the preview

Go deeper on Gnome Diagnostics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Gnome Diagnostics.

Explore the full profile